期刊文献+

曲安奈德玻璃体腔注射治疗葡萄膜炎黄斑囊样水肿疗效 被引量:14

The treatment effects of intravitreal triamcinolone acetonide for uveitis with cystoid macular edema
原文传递
导出
摘要 目的探讨曲安奈德玻璃体腔注射(intravitreal triamcinolone acetonide,IVTA)治疗葡萄膜炎黄斑囊样水肿的疗效和并发症情况。方法回顾性临床自身对照研究。对2008年10月至2010年10月在大连市第三人民医院眼科确诊为葡萄膜炎黄斑囊样水肿的患者10例16只眼,均进行曲安奈德玻璃体腔注射治疗。术后观察视力、眼压、黄斑中心凹厚度、晶状体透明度以及葡萄膜炎复发等。采用治疗前后均数比较f检验。结果术后OCT显示16只眼(100%)黄斑囊样水肿均消失,黄斑中心凹厚度减低。术前黄斑区神经上皮层厚度为(510.63±99.06)μm,术后为(170.25±24.54)μm,两者相比差异有统计学意义(t=11.282,P=0.001)。术后视力均有大幅提高,术后出现继发性青光眼4例5只眼(31.25%),并发性白内障3例4只眼(25%)。随访18个月后葡萄膜炎黄斑囊样水肿复发1例(6.25%)。结论曲安奈德玻璃体腔注射是治疗葡萄膜炎黄斑囊样水肿的有效方法。其并发症有眼压升高和并发性白内障。 Objective To investigate the effects and complications of treatment for uveitis with cystoid macular edema by intravitreal triamcinolone acetonide (IVTA). Methods It was a retrospec- tive case series study. Ten cases (16 eyes) were performed with IVTA. Patients suffering from uve- itis with cystoid macular edema were selected for the study from October 2008 to October 2010 treated in our hospital. The visual acuity, intraocular pressure, foveal thickness, transparency of lens and recurrence of uveitis etc. were examined postoperatively, t test was used for statistics analysis. Results A relief of cystoid macular edema was observed in 16 eyes (100%) after operations. The preoperative mean thickness of foveal was (510,63±99.060)μm while postoperative mean was (170.25±24.541)μm, which was a significant difference (t =11.282, P =0.001). The visual acuity of all pa- tients was improved obviously after operations. Five eyes (31.25%) underwent high intraocular pres- sure, and four eyes (25%) manifested cataract. One eye (6.25%) underwent recurrent uveitis 18 months after the initial treatment. Conclusions Intravitreal triamcinolone acetonide is an effective treatment for uveitis with cystoid macular edema. Complications include high intraocular pressure af- ter IVTA and progression of cataract.
出处 《中国实用眼科杂志》 CSCD 北大核心 2013年第6期676-679,共4页 Chinese Journal of Practical Ophthalmology
关键词 葡萄膜炎 黄斑水肿 囊样 曲安奈德 Uveitis Macular edema Cystoid Triamcinolone acetonide
  • 相关文献

参考文献10

  • 1Okhravi N, Lightman S.Cystoid macular edema in uveitis [J].Ocul Immunol Inflamm, 2003,11(1):29-38.
  • 2Avitabile T, Longo A, Reibaldi A.Intravitreal triamcinolone com-pared with macular laser grid photocoagulation for the treat-ment of cystoid macular edema[J].Am J Ophthalmol,2005,140(4):695-702.
  • 3Terrence Kwong-Weng Soong,Visvaraja Subrayan,Choo May May.玻璃体内注射曲安奈德治疗继发于IRVAN的黄斑水肿(英文)[J].国际眼科杂志,2010,10(11):2058-2059. 被引量:4
  • 4Machemer R,Sugita G,Tano Y.Treatment of intraocular prolifer-ations with intravitreal steroids [J].Trans Am Ophthalmol Soc,1979,77(2):171-180.
  • 5Beer PM, Bakri SJ, Singh RJ, et al.Intraocular concentrationand pharmacokinetics of triamcinolone acetonide aftera singleintravitreal injection[J].Ophthalmology,2003,110(4):681-686.
  • 6王文吉,常青.曲安奈德玻璃体腔注射在视网膜疾病中的应用[J].中国眼耳鼻喉科杂志,2006,6(2):69-71. 被引量:7
  • 7Bandello F,Pognuz DR,Pirracchio A,et al.Intravitreal triamcin-olone acetonide for florid proliferative diabetic retinopathy [J].Graefes Arch Clin Exp Ophthalmol,2004,242(12):1024-1027.
  • 8Ozkiris A,Evereklioglu C,Erkilic K,et al.Intravitreal triamcino-lone acetonide for treatment of persistent macular oedema inbranch retinal vein occlusion[J].Eye,2006,20(l):13-17.
  • 9Habot-Wilner Z, Sallam A, Pacheco PA,et al.Intravitreal triam-cinolone acetonide as adjunctive treatment with systemic thera-py for uveitic macular edema [J].Eur J Ophthalmol, 2011, 21(S6):S56-61.
  • 10Maca SM, Abela-Formanek C, Kiss CG, et aL Intravitreal triam-cinolone for persistent cystoid macular oedema in eyes with qui-escent uveitis [J].Clin Experiment Ophthalmol, 2009, 37(4):389-396.

二级参考文献9

  • 1常青,王文吉.玻璃体内注射曲安奈德治疗黄斑水肿的临床疗效观察[J].中华眼底病杂志,2005,21(4):209-212. 被引量:15
  • 2Chang TS, Aylward GW, Davis JL, Mieler WF, Oliver GL, Maberley AL, Gass JD. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis : Retinal Vasculitis Study. Ophthalmology 1995 ; 102 : 1089-1097.
  • 3Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay D, Yannuzzi LA. Idiopathic Retinitis, Vasculitis, Aneurysms, and Neuroretintis (IRVAN): New Observations and a Proposed Staging System. Ophthalmology 2007 ; 114 : 1526-1529.
  • 4Grover DA, Li T, Chong CCW. lntravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No. : CD005656. DOI: 10. 1002/14651858. CD005656. pub2.
  • 5Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triameinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Eye 2006;20( 1 ) :13-17.
  • 6Matsuda S, Gomi F, Oshima Y, Tohyama M, Tano Y. Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress. Invest Ophthalmol Vis Sci 2005; 46(3):1062-1068.
  • 7Jaissle G,Szurman P, Bartz-Schmidt K. Ocular side effects and complications of intravitreal triamcinolone acetonide injection. Der Opbthalmologe 2004; 101(2): 121-128.
  • 8Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone injection. Am J Ophthalmol, 2003,136:791-796.
  • 9Holecamp NM, Thomas MA, Pear, son A. The safety profile of long-term,high-dose intraocular cor5ticosteroid delivery. Am J Ophthalmol, 2005,139:421-428.

共引文献9

同被引文献150

引证文献14

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部